The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
like wisecrow excellently stated the potash play could be HUGE
Could be some strong upside to come if it works out as well as his last podcast picks (24th April) did (TJI and FDBU). https://www.voxmarkets.co.uk/blogs/467-smudge-dan-alan-green-and-blur-group
14 mins in https://www.voxmarkets.co.uk/blogs/500-toople-com-smudgedan-and-zak-on-the-charts/
Finally started to move
Retailers for the tv
Sony buying ultra D would be good
TV potash play
Im in. Looks like Ultra TV set to hit Dixons, JohnLewis and a few others this year as per website Brasil potash IPO news - great time to buy in
hi mate, Did you used to post a fair bit on Afren board?
Brazilian update as at 28th April http://potassiodobrasil.com.br/uploads/files/bpc_shareholder_update_bfs_28_april_2016-final.pdf
Thanks for this Keny Getting a universal flu Vax is one of main challenges in global pharma and although phase 1 is at least 10 years from market it is the platform that is important rather than the specific viral antigens. The trick is to stimulate the antigenic response to meet the changing nature of the flu pandemic as it reverts to virulence in a different form making current vaccines ineffective against new strains.
Cheers for clarity
Not in yet but researching this w/end. I do like the investments but the only thing I am not sure of is they seem very diverse- potash/ farming/pharma and others and are in LA and Europe so very I am interested in their strategic investment policy but prefer it to be targeted and aligned in one main direction. Was not sure if these investments are historical and are looking to concentrate in specific areas.
Very diverse
The investments look good but very dives with little common strategy. Do you think they are looking to divert som and go in a particular strategic/ geographic direction?
Dr Mike Whelan Universal flu vaccine: bringing an end to the annual flu jab FLUTCORE’s aim is to develop a powerful new universal influenza vaccine that could replace the need for the annual flu jab. FLUTCORE is a consortium of seven partners from four European countries, led by a UK-based business iQur Ltd and includes University College London (UCL) and the University of Leeds. Dr Mike Whelan is the research director at iQur Ltd and the project co-ordinator for the FLUTCORE consortium: Access to knowledge and contacts “This project wouldn’t have happened if it wasn’t for the European Union. I say to everyone who asks me, it’s the access to knowledge that matters – it’s not just about the funding. This knowledge has taken us to the next level.” Dr Whelan’s consortium showcases the powerful effect working on a continental scale can have. His team includes experts based in Leeds and in Latvia, UCL’s bioengineering department, a state-of-the-art genetic sequencing lab in Luxembourg, and world-class clinical testing and manufacturers in Spain. EU support has given Dr Whelan’s team access to previously unknown contacts, knowledge and technologies, as well as lending international profile to his research. For example, his genetic sequencing colleagues in Luxembourg approached him after reading the project’s updates to the EU. Dr Whelan is convinced that he wouldn’t get partnerships like these if the UK left the EU, even if national funding were available: “We wouldn’t get the critical mass,” he says. The scale of the EU makes it possible to manufacture the vaccine on an industrial scale. The UK simply doesn’t have the manufacturing base necessary for his plans – and his Luxembourg colleagues are “working at a level we don’t have in the UK at the moment”. Real life impact Whelan’s team is now gearing up to manufacture the universal flu vaccine. “This is a project that has real life impact for people’s health, but it will also have a positive financial impact on our health service because those annual flu vaccine drives will be a thing of the past. “And for us personally, people are beginning to sit up and take notice of our work. And it was the EU that did that for us.”
First bit of research shows NAV 46p, cash £3.5m and assets worth 26m with two with impending newsflow and a flotation
smudgedan ‏@Smudgedann 3m3 minutes ago @Awkturtle1 yep, Brazilian potash investment looking to float and stream tv linking with major tv manufacturers so can see that floating
cash at 3.5 mill in cash and assets worth 23 million Nav@ 46P whats not to like
Shore
Boom Buyers on it
Can't hold for a recovery that might never happen. The SP is in a death spiral and only some asset realisation will turn it round. It went through my stop loss and I am disillusioned. I should have know when they can't be bothered to even answered the phone.
...ever come to life? Huge discount to NAV and promised to do asset realisation. I wonder will anything happen by the year end, any year end?
still the price is steady. When I last spoke to the company they said the results might be out in early July. Definitely a share in search of direction. Potential is huge, it just needs to cash in on its investments.